VFG
BSX icon

Victory Financial Group’s Boston Scientific BSX Stock Holding History

Victory Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,437
Closed -$216K – 403
2026
Q1 		$216K Buy
3,437
+603
+21% +$48.2K 0.03% 325
2025
Q4 		$270K Buy
2,834
+618
+28% +$60.6K 0.03% 252
2025
Q3 		$216K Buy
2,216
+278
+14% +$28.8K 0.03% 234
2025
Q2 		$208K Sell
1,938
-157
-7% -$15.9K 0.03% 215
2025
Q1 		$212K Buy
+2,095
New +$211K 0.04% 166

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Victory Financial Group's BSX Position: Q2 2026 in Review

Victory Financial Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,437 shares — an estimated $216K sold.

Victory Financial Group first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $270K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Victory Financial Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Victory Financial Group sold 3,437 Boston Scientific shares in Q2 2026, an estimated $216K.
  • Victory Financial Group first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • Victory Financial Group's Boston Scientific position peaked at $270K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.